Electronic Proactive Outreach for Smokers With COPD
- Conditions
- SmokingPulmonary Disease, Chronic Obstructive
- Interventions
- Behavioral: Proactive Outreach
- Registration Number
- NCT04462289
- Lead Sponsor
- VA Office of Research and Development
- Brief Summary
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases, with 90% of cases directly attributable to smoking. Unfortunately, many patients continue to smoke and have an urgent need to quit. Proactive tobacco treatment programs identify patients outside of a routine clinical appointment and engage them in making a supported quit attempt.
Most previous research of proactive tobacco treatment has used telephone outreach, which can be resource intensive. Electronic methods (texting, secure messaging) may be effective while requiring fewer resources.
In this study, a previously tested telephone outreach intervention will be adapted for electronic delivery, with content tailored to smokers with COPD. First, information will be gathered from smokers with COPD and the medical staff who care for them to adapt the program for electronic delivery. Then, the program will be pilot-tested. Smokers with COPD will be randomly assigned to either usual medical care or the outreach intervention, with goals to increase participation in smoking cessation programs, quit attempts, and successful cessation.
- Detailed Description
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory conditions and the 4th leading cause of death in the US. 90% of cases are directly attributable to smoking. Quitting smoking is the most important intervention for these patients, who continue to smoke at rates double the national average. Smokers with COPD remain undertreated for tobacco use. Proactive tobacco treatment programs identify patients outside of a routine clinic visit, engage them in making a quit attempt and connect them with treatment. These programs may be particularly beneficial for smokers with COPD. Previous phone-based programs are resource intensive to deliver. Electronic methods for delivering proactive outreach for tobacco cessation may be effective and cost-effective, and can be tailored to the target population.
Hypothesis: A proactive tobacco treatment program adapted to electronic delivery and tailored to smokers with COPD will be effective and cost effective for increasing quit engagement among smokers with COPD.
Study design: Multi-aim implementation study with randomized pilot. Aim 1: Mixed methods (survey and interview) assessment of current use of health information technology among smokers with COPD with a focus on the impact of the chronic disease state on tobacco cessation.
Aim 2: Qualitative assessment of barriers and facilitators to implementation of proactive tobacco treatment programs for patients with COPD among staff and leadership.
Aim 3: Randomized pilot of a proactive tobacco treatment program for smokers with COPD delivered through phone and text messaging.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 126
- Veterans active in clinical care (at least one primary care or pulmonary visit within the past year)
- Past-year smoking status in the electronic health record indicating current smoking, confirmed on enrollment call
- Diagnosed with COPD (2 ICD-10 diagnoses of COPD within the past 2 years)
- Currently enrolled in MyHealtheVet secure messaging
- Already enrolled in behavioral VA tobacco treatment
- Enrolled in hospice
- Undergoing active cancer treatment
- Advanced dementia
- Unable to communicate in English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Proactive Outreach Proactive Outreach Randomly assigned sample who will receive a proactive offer of tobacco treatment with connection to motivational texting program.
- Primary Outcome Measures
Name Time Method Response to outreach intervention 60 days Proportion of participants who respond to the proactive offer, feasibility outcome
- Secondary Outcome Measures
Name Time Method Rate of Smoking cessation 6 months Self-reported and biochemically confirmed smoking cessation
Marginal Cost 6 months Cost associated with the proactive program, encompassing both direct costs and indirect costs related to increased use of quit resources and medications
Participation in tobacco cessation treatment 6 months Any participation in tobacco cessation treatment (medication use, counseling)
Number of Quit attempts 6 months Self-reported attempts to quit smoking
Trial Locations
- Locations (1)
Minneapolis VA Health Care System, Minneapolis, MN
🇺🇸Minneapolis, Minnesota, United States